

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.34871388 |
| 2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 6.12359661 |
| 3 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.07920056 |
| 4 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.90861020 |
| 5 | response to interleukin-15 (GO:0070672) | 5.86234794 |
| 6 | DNA deamination (GO:0045006) | 5.74271305 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.52423739 |
| 8 | tyrosine phosphorylation of STAT protein (GO:0007260) | 5.46133851 |
| 9 | cytidine deamination (GO:0009972) | 5.45795356 |
| 10 | cytidine metabolic process (GO:0046087) | 5.45795356 |
| 11 | cytidine catabolic process (GO:0006216) | 5.45795356 |
| 12 | negative T cell selection (GO:0043383) | 5.19337187 |
| 13 | positive regulation of T cell cytokine production (GO:0002726) | 5.15837190 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.09697157 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 5.08943522 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.08700713 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07086991 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07086991 |
| 19 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.99310523 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.94744455 |
| 21 | positive regulation of isotype switching (GO:0045830) | 4.90186576 |
| 22 | regulation of regulatory T cell differentiation (GO:0045589) | 4.72527952 |
| 23 | interferon-gamma production (GO:0032609) | 4.70591246 |
| 24 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.69793791 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.60996736 |
| 26 | regulation of immunoglobulin secretion (GO:0051023) | 4.50606293 |
| 27 | * positive regulation of B cell mediated immunity (GO:0002714) | 4.46689626 |
| 28 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.46689626 |
| 29 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.43671679 |
| 30 | regulation of response to tumor cell (GO:0002834) | 4.37762592 |
| 31 | positive regulation of response to tumor cell (GO:0002836) | 4.37762592 |
| 32 | positive regulation of immune response to tumor cell (GO:0002839) | 4.37762592 |
| 33 | regulation of immune response to tumor cell (GO:0002837) | 4.37762592 |
| 34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.32759741 |
| 35 | myeloid dendritic cell differentiation (GO:0043011) | 4.30560882 |
| 36 | positive regulation of immunoglobulin production (GO:0002639) | 4.28319981 |
| 37 | positive regulation of interleukin-2 production (GO:0032743) | 4.26697673 |
| 38 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.21968074 |
| 39 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.20643498 |
| 40 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.19920258 |
| 41 | positive regulation of DNA recombination (GO:0045911) | 4.18495399 |
| 42 | positive T cell selection (GO:0043368) | 4.15580240 |
| 43 | * regulation of chronic inflammatory response (GO:0002676) | 4.11471221 |
| 44 | tolerance induction (GO:0002507) | 4.08370646 |
| 45 | thymic T cell selection (GO:0045061) | 4.05950688 |
| 46 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.05072114 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98430429 |
| 48 | maturation of 5.8S rRNA (GO:0000460) | 3.94250685 |
| 49 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.92841355 |
| 50 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.92841355 |
| 51 | myeloid dendritic cell activation (GO:0001773) | 3.91164620 |
| 52 | positive regulation of activated T cell proliferation (GO:0042104) | 3.90731168 |
| 53 | activated T cell proliferation (GO:0050798) | 3.88561761 |
| 54 | T cell lineage commitment (GO:0002360) | 3.85683133 |
| 55 | regulation of immunoglobulin production (GO:0002637) | 3.84490741 |
| 56 | T cell selection (GO:0045058) | 3.84362600 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 3.80774434 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.79763879 |
| 59 | regulation of interleukin-2 production (GO:0032663) | 3.77077895 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.75972580 |
| 61 | leukocyte aggregation (GO:0070486) | 3.73816799 |
| 62 | regulation of isotype switching (GO:0045191) | 3.72961124 |
| 63 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.72112899 |
| 64 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.71485859 |
| 65 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.70959754 |
| 66 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.68790833 |
| 67 | rRNA modification (GO:0000154) | 3.68570870 |
| 68 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.68309922 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.65859429 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.65859429 |
| 71 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.64305408 |
| 72 | T cell costimulation (GO:0031295) | 3.63020832 |
| 73 | T cell migration (GO:0072678) | 3.61810389 |
| 74 | regulation of T cell chemotaxis (GO:0010819) | 3.59755469 |
| 75 | positive regulation of T cell chemotaxis (GO:0010820) | 3.59755469 |
| 76 | T cell homeostasis (GO:0043029) | 3.57848900 |
| 77 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.57520849 |
| 78 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.57520849 |
| 79 | * regulation of B cell mediated immunity (GO:0002712) | 3.57032143 |
| 80 | lymphocyte costimulation (GO:0031294) | 3.55101952 |
| 81 | positive regulation of cell killing (GO:0031343) | 3.54217393 |
| 82 | regulation of T cell cytokine production (GO:0002724) | 3.53780593 |
| 83 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.50334962 |
| 84 | positive regulation of interleukin-17 production (GO:0032740) | 3.49279328 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.49278110 |
| 86 | T cell receptor signaling pathway (GO:0050852) | 3.46140696 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46026288 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.45533849 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.45533849 |
| 90 | rRNA methylation (GO:0031167) | 3.45431820 |
| 91 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.42107893 |
| 92 | negative regulation of cell killing (GO:0031342) | 3.42107893 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41462925 |
| 94 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.40832778 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 3.36560155 |
| 96 | proteasome assembly (GO:0043248) | 3.36431147 |
| 97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.36341548 |
| 98 | mast cell activation (GO:0045576) | 3.35859391 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34986134 |
| 100 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.33868622 |
| 101 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.32073627 |
| 102 | Peyers patch development (GO:0048541) | 3.32073627 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.30462257 |
| 104 | positive regulation of macrophage differentiation (GO:0045651) | 3.29347119 |
| 105 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27265949 |
| 106 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.26864599 |
| 107 | regulation of T-helper 1 type immune response (GO:0002825) | 3.25623649 |
| 108 | regulation of B cell differentiation (GO:0045577) | 3.25376110 |
| 109 | defense response to protozoan (GO:0042832) | 3.24514122 |
| 110 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.22563376 |
| 111 | natural killer cell differentiation (GO:0001779) | 3.22043854 |
| 112 | T cell proliferation (GO:0042098) | 3.21464406 |
| 113 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.20635276 |
| 114 | regulation of cell killing (GO:0031341) | 3.20412319 |
| 115 | natural killer cell activation (GO:0030101) | 3.20369233 |
| 116 | positive regulation of interleukin-10 production (GO:0032733) | 3.19588413 |
| 117 | * regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15936110 |
| 118 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.15395910 |
| 119 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14171206 |
| 120 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.13652057 |
| 121 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.13133388 |
| 122 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.13133388 |
| 123 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.12715621 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 3.11868769 |
| 125 | hepatocyte apoptotic process (GO:0097284) | 3.10921984 |
| 126 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.10157925 |
| 127 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.10157925 |
| 128 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.10157925 |
| 129 | positive regulation of T cell proliferation (GO:0042102) | 3.10024053 |
| 130 | ribosome assembly (GO:0042255) | 3.09295912 |
| 131 | T cell apoptotic process (GO:0070231) | 3.09096005 |
| 132 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.08884712 |
| 133 | response to protozoan (GO:0001562) | 3.08784312 |
| 134 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.08391912 |
| 135 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.08308820 |
| 136 | positive regulation of astrocyte differentiation (GO:0048711) | 3.07383120 |
| 137 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.06380482 |
| 138 | cellular response to interleukin-4 (GO:0071353) | 3.06053524 |
| 139 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.04693844 |
| 140 | rRNA processing (GO:0006364) | 3.04424095 |
| 141 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.98470340 |
| 142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.98470340 |
| 143 | positive regulation of prostaglandin secretion (GO:0032308) | 2.95650434 |
| 144 | * positive regulation of humoral immune response (GO:0002922) | 2.93241223 |
| 145 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.92214026 |
| 146 | T cell differentiation involved in immune response (GO:0002292) | 2.91387072 |
| 147 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.91387072 |
| 148 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.91387072 |
| 149 | rRNA metabolic process (GO:0016072) | 2.91306475 |
| 150 | T-helper cell differentiation (GO:0042093) | 2.88517329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.05684327 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74974878 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.69183506 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.25149298 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12319081 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.89711782 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82354229 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.81650674 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.62179204 |
| 10 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.44664932 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37944510 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20505286 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.11545650 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97851580 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.71725441 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.70432513 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.64762170 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.64409167 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.62591522 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61897760 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.52689422 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.50803948 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49317590 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.49100789 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36473906 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.31425821 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.18011123 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17268841 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.16506103 |
| 30 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14807252 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06045925 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.99394499 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95893723 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91556592 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.90477813 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87668017 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86698364 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85934474 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85241305 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80949598 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79917906 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74889097 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74888944 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72444350 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69925248 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.68147941 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68061039 |
| 48 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67361855 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64683210 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63707241 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63153736 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.61258479 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59681439 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58654311 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58580016 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55075098 |
| 57 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54560329 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48393055 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.47731431 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43522865 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42842644 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41143225 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40050357 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37979192 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36990105 |
| 66 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35228294 |
| 67 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32503242 |
| 68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32027859 |
| 69 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31820382 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31487251 |
| 71 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.22213044 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21505617 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21432204 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21363817 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20211690 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18460734 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16362762 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15257779 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14818625 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12722019 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09415447 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08493729 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08137838 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06146592 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06053401 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06016759 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05262141 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04181647 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99656232 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99111646 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98543410 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98539209 |
| 93 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.97727470 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97654376 |
| 95 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97093459 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96246113 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.95345542 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94506301 |
| 99 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94023446 |
| 100 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93845519 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93309007 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92168218 |
| 103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91363852 |
| 104 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91193950 |
| 105 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90423836 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89405204 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87334551 |
| 108 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86297575 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.85187028 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85105597 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84991331 |
| 112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84721496 |
| 113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.83958453 |
| 114 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.83688767 |
| 115 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.83584479 |
| 116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83128961 |
| 117 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83045185 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82896168 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82755246 |
| 120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.80775813 |
| 121 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80234171 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79517649 |
| 123 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79245674 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79038999 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79029858 |
| 126 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78555847 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78515286 |
| 128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77054591 |
| 129 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76655882 |
| 130 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75304607 |
| 131 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.73849615 |
| 132 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73481129 |
| 133 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.72658435 |
| 134 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72548296 |
| 135 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72267955 |
| 136 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70897572 |
| 137 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.69751580 |
| 138 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68395511 |
| 139 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.68067594 |
| 140 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.66232062 |
| 141 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.65757913 |
| 142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65584070 |
| 143 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.65543013 |
| 144 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.65494588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.32246629 |
| 2 | MP0005671_abnormal_response_to | 4.26622598 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.14450382 |
| 4 | MP0001790_abnormal_immune_system | 3.58144866 |
| 5 | MP0005387_immune_system_phenotype | 3.58144866 |
| 6 | * MP0001800_abnormal_humoral_immune | 3.54153631 |
| 7 | * MP0000685_abnormal_immune_system | 3.27580117 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.24236383 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.01278043 |
| 10 | * MP0003436_decreased_susceptibility_to | 3.00309653 |
| 11 | * MP0002723_abnormal_immune_serum | 2.92111030 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.89063289 |
| 13 | MP0003866_abnormal_defecation | 2.86818200 |
| 14 | * MP0009785_altered_susceptibility_to | 2.85394466 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.74814968 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.73343900 |
| 17 | * MP0002398_abnormal_bone_marrow | 2.72539738 |
| 18 | MP0003303_peritoneal_inflammation | 2.70607862 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.67017062 |
| 20 | * MP0001819_abnormal_immune_cell | 2.62569674 |
| 21 | * MP0002405_respiratory_system_inflammati | 2.60411553 |
| 22 | * MP0005025_abnormal_response_to | 2.52185438 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.49742616 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.44019209 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.35445410 |
| 26 | MP0001853_heart_inflammation | 2.34440610 |
| 27 | * MP0000716_abnormal_immune_system | 2.33712274 |
| 28 | MP0002006_tumorigenesis | 2.28169342 |
| 29 | MP0006082_CNS_inflammation | 2.21504346 |
| 30 | * MP0000689_abnormal_spleen_morphology | 2.21002792 |
| 31 | MP0004510_myositis | 2.19509062 |
| 32 | * MP0000703_abnormal_thymus_morphology | 2.19421065 |
| 33 | * MP0002722_abnormal_immune_system | 2.14007010 |
| 34 | MP0001873_stomach_inflammation | 1.99708659 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.98518879 |
| 36 | MP0002933_joint_inflammation | 1.97946673 |
| 37 | * MP0002429_abnormal_blood_cell | 1.93579835 |
| 38 | * MP0002419_abnormal_innate_immunity | 1.76677244 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.75113789 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.73827569 |
| 41 | MP0004947_skin_inflammation | 1.72789802 |
| 42 | MP0003724_increased_susceptibility_to | 1.70603721 |
| 43 | MP0008057_abnormal_DNA_replication | 1.55489606 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.44467448 |
| 45 | MP0002254_reproductive_system_inflammat | 1.42003897 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.30614699 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.30051273 |
| 48 | MP0003646_muscle_fatigue | 1.25844505 |
| 49 | MP0005310_abnormal_salivary_gland | 1.22479011 |
| 50 | MP0008872_abnormal_physiological_respon | 1.21059040 |
| 51 | MP0003448_altered_tumor_morphology | 1.20469288 |
| 52 | MP0000490_abnormal_crypts_of | 1.19882755 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.18985543 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.16562289 |
| 55 | MP0000858_altered_metastatic_potential | 1.13234919 |
| 56 | * MP0001533_abnormal_skeleton_physiology | 1.10906121 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.10834175 |
| 58 | MP0000604_amyloidosis | 1.09782539 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.09348200 |
| 60 | * MP0008469_abnormal_protein_level | 1.09103322 |
| 61 | MP0003045_fibrosis | 1.05652978 |
| 62 | MP0010307_abnormal_tumor_latency | 1.05250903 |
| 63 | MP0001881_abnormal_mammary_gland | 1.03636166 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.02989553 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.00585298 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.00504995 |
| 67 | MP0003077_abnormal_cell_cycle | 0.99519334 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.98019165 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.98019165 |
| 70 | MP0008961_abnormal_basal_metabolism | 0.93296276 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 0.92428799 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.92351053 |
| 73 | MP0001919_abnormal_reproductive_system | 0.88091762 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 0.86628316 |
| 75 | MP0004381_abnormal_hair_follicle | 0.86054726 |
| 76 | MP0005408_hypopigmentation | 0.85570309 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.81576492 |
| 78 | MP0005451_abnormal_body_composition | 0.80676152 |
| 79 | MP0004142_abnormal_muscle_tone | 0.80252883 |
| 80 | MP0001727_abnormal_embryo_implantation | 0.79567824 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.75438361 |
| 82 | MP0001661_extended_life_span | 0.73378201 |
| 83 | MP0003959_abnormal_lean_body | 0.70872186 |
| 84 | MP0004742_abnormal_vestibular_system | 0.69696076 |
| 85 | MP0000627_abnormal_mammary_gland | 0.67569302 |
| 86 | MP0000350_abnormal_cell_proliferation | 0.66624965 |
| 87 | MP0001851_eye_inflammation | 0.66439976 |
| 88 | MP0003111_abnormal_nucleus_morphology | 0.66021277 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.65863557 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65368239 |
| 91 | MP0002132_abnormal_respiratory_system | 0.65336664 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.63035134 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.61965312 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.60272437 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.59745716 |
| 96 | MP0002163_abnormal_gland_morphology | 0.59573409 |
| 97 | * MP0009764_decreased_sensitivity_to | 0.59444896 |
| 98 | MP0000313_abnormal_cell_death | 0.58834399 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.58822466 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.58286643 |
| 101 | MP0009278_abnormal_bone_marrow | 0.57283069 |
| 102 | MP0001663_abnormal_digestive_system | 0.56311379 |
| 103 | MP0005166_decreased_susceptibility_to | 0.55470607 |
| 104 | MP0003091_abnormal_cell_migration | 0.55111681 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.54258688 |
| 106 | MP0005023_abnormal_wound_healing | 0.54094625 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.54032839 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54024414 |
| 109 | MP0001730_embryonic_growth_arrest | 0.53974928 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.53343191 |
| 111 | MP0003878_abnormal_ear_physiology | 0.52857755 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.52857755 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.51959386 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.51611299 |
| 115 | MP0000371_diluted_coat_color | 0.51278094 |
| 116 | * MP0000609_abnormal_liver_physiology | 0.50907447 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.50861281 |
| 118 | MP0003786_premature_aging | 0.50598810 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.47805853 |
| 120 | * MP0009763_increased_sensitivity_to | 0.47668036 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.46639584 |
| 122 | MP0000249_abnormal_blood_vessel | 0.45678147 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.45647362 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.45158389 |
| 125 | MP0003795_abnormal_bone_structure | 0.45004922 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.44859452 |
| 127 | MP0001216_abnormal_epidermal_layer | 0.42121404 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.40917473 |
| 129 | MP0008058_abnormal_DNA_repair | 0.40632939 |
| 130 | MP0002083_premature_death | 0.39782551 |
| 131 | MP0003943_abnormal_hepatobiliary_system | 0.39354520 |
| 132 | MP0003984_embryonic_growth_retardation | 0.38619369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.36176617 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.25240079 |
| 3 | Stomatitis (HP:0010280) | 6.06040558 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.81425509 |
| 5 | Recurrent fungal infections (HP:0002841) | 5.18251001 |
| 6 | IgA deficiency (HP:0002720) | 5.15761849 |
| 7 | Abnormality of T cells (HP:0002843) | 5.15184426 |
| 8 | Recurrent bronchitis (HP:0002837) | 5.04069919 |
| 9 | Recurrent viral infections (HP:0004429) | 4.99339937 |
| 10 | Chronic diarrhea (HP:0002028) | 4.69557037 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.60841098 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.60841098 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.57526560 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.38078547 |
| 15 | Nasal polyposis (HP:0100582) | 4.32125010 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.28947448 |
| 17 | Chronic otitis media (HP:0000389) | 4.23946926 |
| 18 | IgM deficiency (HP:0002850) | 4.09898036 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 4.06194226 |
| 20 | IgG deficiency (HP:0004315) | 4.01367532 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.97456911 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.96167120 |
| 23 | Acute encephalopathy (HP:0006846) | 3.88225742 |
| 24 | Combined immunodeficiency (HP:0005387) | 3.86172483 |
| 25 | Thrombocytosis (HP:0001894) | 3.74577105 |
| 26 | Increased IgM level (HP:0003496) | 3.73707167 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 3.71959057 |
| 28 | Increased density of long bones (HP:0006392) | 3.69561458 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.61424948 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.54908905 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.52751131 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.51747842 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.51018767 |
| 34 | Vasculitis (HP:0002633) | 3.43600832 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 3.37840202 |
| 36 | Lymphopenia (HP:0001888) | 3.34221011 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.34042234 |
| 38 | Gastrointestinal stroma tumor (HP:0100723) | 3.33157037 |
| 39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.31360619 |
| 40 | Progressive macrocephaly (HP:0004481) | 3.26888446 |
| 41 | Joint swelling (HP:0001386) | 3.25280685 |
| 42 | Abnormality of the fingertips (HP:0001211) | 3.23779374 |
| 43 | Inflammation of the large intestine (HP:0002037) | 3.21082866 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 3.19330658 |
| 45 | Increased CSF lactate (HP:0002490) | 3.16578338 |
| 46 | Anorexia (HP:0002039) | 3.10359365 |
| 47 | Myositis (HP:0100614) | 3.07881532 |
| 48 | Meningitis (HP:0001287) | 3.05123741 |
| 49 | Lymphoma (HP:0002665) | 3.01049930 |
| 50 | Pulmonary infiltrates (HP:0002113) | 3.00688935 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.96936252 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.95596659 |
| 53 | Cellulitis (HP:0100658) | 2.94763596 |
| 54 | Chronic sinusitis (HP:0011109) | 2.90216470 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.89348243 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.85405156 |
| 57 | B lymphocytopenia (HP:0010976) | 2.85405156 |
| 58 | Persistence of primary teeth (HP:0006335) | 2.83425692 |
| 59 | Hemoptysis (HP:0002105) | 2.82348045 |
| 60 | Cheilitis (HP:0100825) | 2.82077045 |
| 61 | Gangrene (HP:0100758) | 2.80086006 |
| 62 | Bronchitis (HP:0012387) | 2.77732280 |
| 63 | Recurrent skin infections (HP:0001581) | 2.73486828 |
| 64 | Abnormal pupillary function (HP:0007686) | 2.72299051 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.72208672 |
| 66 | Hypergammaglobulinemia (HP:0010702) | 2.71770196 |
| 67 | Arterial thrombosis (HP:0004420) | 2.70629580 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 2.68554043 |
| 69 | Abnormality of the anterior horn cell (HP:0006802) | 2.63536134 |
| 70 | Degeneration of anterior horn cells (HP:0002398) | 2.63536134 |
| 71 | Emphysema (HP:0002097) | 2.63129902 |
| 72 | Premature loss of primary teeth (HP:0006323) | 2.62875026 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.61185732 |
| 74 | Verrucae (HP:0200043) | 2.61160536 |
| 75 | Papilloma (HP:0012740) | 2.61160536 |
| 76 | Pancytopenia (HP:0001876) | 2.59182221 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.59025934 |
| 78 | Thyroiditis (HP:0100646) | 2.58676001 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.58128695 |
| 80 | Leukocytosis (HP:0001974) | 2.52132854 |
| 81 | Oral leukoplakia (HP:0002745) | 2.49762826 |
| 82 | Cerebral edema (HP:0002181) | 2.49373643 |
| 83 | Fatigue (HP:0012378) | 2.48114674 |
| 84 | Keratoconjunctivitis sicca (HP:0001097) | 2.46215190 |
| 85 | Chest pain (HP:0100749) | 2.44981190 |
| 86 | Recurrent abscess formation (HP:0002722) | 2.43470663 |
| 87 | Pustule (HP:0200039) | 2.42661997 |
| 88 | Optic neuritis (HP:0100653) | 2.42580225 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.42580225 |
| 90 | Increased IgE level (HP:0003212) | 2.41584102 |
| 91 | Amaurosis fugax (HP:0100576) | 2.37255017 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.35658094 |
| 93 | Eosinophilia (HP:0001880) | 2.35042999 |
| 94 | Aplastic anemia (HP:0001915) | 2.34851407 |
| 95 | Nausea (HP:0002018) | 2.28432124 |
| 96 | Increased muscle lipid content (HP:0009058) | 2.28403160 |
| 97 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.24851551 |
| 98 | Obstructive lung disease (HP:0006536) | 2.24849900 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24849900 |
| 100 | Abnormality of the pons (HP:0007361) | 2.24739145 |
| 101 | Exertional dyspnea (HP:0002875) | 2.19850160 |
| 102 | Optic disc pallor (HP:0000543) | 2.19737376 |
| 103 | Arthralgia (HP:0002829) | 2.18945238 |
| 104 | Colitis (HP:0002583) | 2.17252083 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16969588 |
| 106 | Increased serum lactate (HP:0002151) | 2.15827693 |
| 107 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.13283018 |
| 108 | Leukopenia (HP:0001882) | 2.10943299 |
| 109 | Hepatosplenomegaly (HP:0001433) | 2.10524035 |
| 110 | Osteomyelitis (HP:0002754) | 2.09540524 |
| 111 | Granulocytopenia (HP:0001913) | 2.08547858 |
| 112 | Skin ulcer (HP:0200042) | 2.05096765 |
| 113 | Gingival bleeding (HP:0000225) | 2.04635285 |
| 114 | Hypertensive crisis (HP:0100735) | 2.03396208 |
| 115 | Hypoplasia of the thymus (HP:0000778) | 2.03358553 |
| 116 | Orchitis (HP:0100796) | 2.01106332 |
| 117 | Hypoplasia of the pons (HP:0012110) | 2.00789361 |
| 118 | Porencephaly (HP:0002132) | 1.99439009 |
| 119 | Recurrent bacterial skin infections (HP:0005406) | 1.99131093 |
| 120 | Restrictive lung disease (HP:0002091) | 1.98885753 |
| 121 | Leukodystrophy (HP:0002415) | 1.96923394 |
| 122 | Hepatocellular necrosis (HP:0001404) | 1.96595602 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.96334249 |
| 124 | Acute myeloid leukemia (HP:0004808) | 1.95657198 |
| 125 | Basal cell carcinoma (HP:0002671) | 1.95618044 |
| 126 | Myocardial infarction (HP:0001658) | 1.95588418 |
| 127 | Cutis marmorata (HP:0000965) | 1.95176801 |
| 128 | Respiratory difficulties (HP:0002880) | 1.94533850 |
| 129 | Exercise intolerance (HP:0003546) | 1.94176886 |
| 130 | Chronic hepatic failure (HP:0100626) | 1.94059374 |
| 131 | Encephalitis (HP:0002383) | 1.93948685 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.93454025 |
| 133 | Cholecystitis (HP:0001082) | 1.93454025 |
| 134 | Duplicated collecting system (HP:0000081) | 1.92081326 |
| 135 | Hepatic necrosis (HP:0002605) | 1.91612543 |
| 136 | Methylmalonic acidemia (HP:0002912) | 1.91410277 |
| 137 | Hypoproteinemia (HP:0003075) | 1.90420878 |
| 138 | Paralysis (HP:0003470) | 1.88200374 |
| 139 | Methylmalonic aciduria (HP:0012120) | 1.87427723 |
| 140 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86876110 |
| 141 | Acrocyanosis (HP:0001063) | 1.83293808 |
| 142 | Periodontitis (HP:0000704) | 1.81311356 |
| 143 | Spontaneous hematomas (HP:0007420) | 1.81260505 |
| 144 | Recurrent otitis media (HP:0000403) | 1.81183995 |
| 145 | Somatic mutation (HP:0001428) | 1.79769840 |
| 146 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74501396 |
| 147 | Skin rash (HP:0000988) | 1.74480816 |
| 148 | Poikiloderma (HP:0001029) | 1.74022668 |
| 149 | Hepatitis (HP:0012115) | 1.70730660 |
| 150 | Abnormality of the endocardium (HP:0004306) | 1.67432880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.21787399 |
| 2 | TXK | 4.98792228 |
| 3 | JAK3 | 4.17098540 |
| 4 | SRPK1 | 3.61532429 |
| 5 | ZAP70 | 3.22104707 |
| 6 | MAPKAPK3 | 3.18050182 |
| 7 | MAP3K14 | 3.02172624 |
| 8 | EEF2K | 2.95850087 |
| 9 | EIF2AK3 | 2.84332696 |
| 10 | TLK1 | 2.77855593 |
| 11 | TRIM28 | 2.75632645 |
| 12 | ITK | 2.65492607 |
| 13 | EIF2AK1 | 2.33753299 |
| 14 | IKBKE | 2.25233225 |
| 15 | TYK2 | 2.16525934 |
| 16 | WNK4 | 2.13300961 |
| 17 | FGFR4 | 2.13091590 |
| 18 | BUB1 | 2.10084913 |
| 19 | PIM2 | 2.06646532 |
| 20 | TBK1 | 1.99722441 |
| 21 | TRIB3 | 1.89202659 |
| 22 | TAOK3 | 1.83619149 |
| 23 | STK10 | 1.80326321 |
| 24 | BLK | 1.79355623 |
| 25 | IKBKB | 1.76088834 |
| 26 | TEC | 1.75893708 |
| 27 | BTK | 1.74330504 |
| 28 | MAP3K10 | 1.71921724 |
| 29 | SYK | 1.70446343 |
| 30 | LCK | 1.64463318 |
| 31 | EIF2AK2 | 1.61599420 |
| 32 | CHUK | 1.61263370 |
| 33 | JAK1 | 1.60071103 |
| 34 | VRK2 | 1.55114142 |
| 35 | FGFR3 | 1.52007498 |
| 36 | PKN2 | 1.45070981 |
| 37 | MST4 | 1.44867978 |
| 38 | HCK | 1.44766018 |
| 39 | CSK | 1.43969219 |
| 40 | CDK12 | 1.43586304 |
| 41 | NLK | 1.40842802 |
| 42 | MAP3K13 | 1.29347530 |
| 43 | GRK6 | 1.28824564 |
| 44 | RPS6KA4 | 1.26245740 |
| 45 | ADRBK2 | 1.22568245 |
| 46 | PRKCH | 1.20728394 |
| 47 | NME2 | 1.19259505 |
| 48 | CLK1 | 1.16796889 |
| 49 | ALK | 1.15569261 |
| 50 | PIM1 | 1.14901166 |
| 51 | SIK2 | 1.10294430 |
| 52 | DAPK1 | 1.10237445 |
| 53 | WNK1 | 1.09593979 |
| 54 | SMG1 | 1.08542634 |
| 55 | MAP3K7 | 1.07779146 |
| 56 | VRK1 | 1.00471882 |
| 57 | JAK2 | 0.99273529 |
| 58 | MAP2K6 | 0.98949079 |
| 59 | LRRK2 | 0.97549140 |
| 60 | PRKCQ | 0.97096670 |
| 61 | LYN | 0.95700709 |
| 62 | TAOK1 | 0.94705893 |
| 63 | CAMKK2 | 0.94306352 |
| 64 | EPHA3 | 0.88195116 |
| 65 | PASK | 0.87684118 |
| 66 | TSSK6 | 0.85562686 |
| 67 | MAP3K11 | 0.85339385 |
| 68 | ZAK | 0.80902042 |
| 69 | CDK4 | 0.80231361 |
| 70 | STK39 | 0.80156051 |
| 71 | EPHB1 | 0.80098340 |
| 72 | MAP3K12 | 0.78739575 |
| 73 | NEK1 | 0.78689049 |
| 74 | RAF1 | 0.78575732 |
| 75 | CDC7 | 0.75100413 |
| 76 | CSF1R | 0.72854754 |
| 77 | IRAK4 | 0.71387114 |
| 78 | KIT | 0.68393276 |
| 79 | PLK3 | 0.65419777 |
| 80 | MAPK11 | 0.62485959 |
| 81 | NEK6 | 0.62478342 |
| 82 | FES | 0.62227286 |
| 83 | MAP3K8 | 0.58979088 |
| 84 | MARK3 | 0.56031300 |
| 85 | BCKDK | 0.54446120 |
| 86 | NUAK1 | 0.54237315 |
| 87 | STK16 | 0.53858901 |
| 88 | MAP2K3 | 0.53435259 |
| 89 | NEK2 | 0.51888819 |
| 90 | SIK3 | 0.50063102 |
| 91 | RIPK4 | 0.50011858 |
| 92 | CDC42BPA | 0.48781722 |
| 93 | TGFBR1 | 0.48224107 |
| 94 | FGFR1 | 0.47496348 |
| 95 | SIK1 | 0.47113791 |
| 96 | OXSR1 | 0.46981482 |
| 97 | PDK1 | 0.46743756 |
| 98 | MAP3K9 | 0.46369440 |
| 99 | MAPKAPK2 | 0.45711683 |
| 100 | PIK3CG | 0.44991847 |
| 101 | TNK2 | 0.44835659 |
| 102 | KDR | 0.44439484 |
| 103 | ERN1 | 0.44225777 |
| 104 | IRAK1 | 0.43594522 |
| 105 | PAK2 | 0.43470070 |
| 106 | PBK | 0.42991037 |
| 107 | TAF1 | 0.42479877 |
| 108 | CHEK1 | 0.40708464 |
| 109 | EGFR | 0.40616435 |
| 110 | PRKCI | 0.39768677 |
| 111 | MAP3K5 | 0.39763923 |
| 112 | CAMKK1 | 0.38174508 |
| 113 | BRD4 | 0.37824975 |
| 114 | PTK6 | 0.36935538 |
| 115 | NEK9 | 0.36847327 |
| 116 | CDK19 | 0.35864992 |
| 117 | RPS6KB1 | 0.35110449 |
| 118 | TESK2 | 0.34603342 |
| 119 | INSR | 0.33684201 |
| 120 | HIPK2 | 0.31835157 |
| 121 | RPS6KA5 | 0.31541226 |
| 122 | CSNK2A2 | 0.31123203 |
| 123 | BMX | 0.30798383 |
| 124 | RPS6KA1 | 0.30421755 |
| 125 | MARK2 | 0.29123710 |
| 126 | ABL1 | 0.28661414 |
| 127 | CDK7 | 0.28168312 |
| 128 | MELK | 0.27719860 |
| 129 | STK4 | 0.27373347 |
| 130 | MAPK4 | 0.25607274 |
| 131 | TAOK2 | 0.25436507 |
| 132 | CSNK1G3 | 0.24230315 |
| 133 | MTOR | 0.23255948 |
| 134 | SCYL2 | 0.23162175 |
| 135 | PRKCB | 0.22321124 |
| 136 | ATR | 0.22078648 |
| 137 | TTN | 0.21970119 |
| 138 | NME1 | 0.21578118 |
| 139 | BMPR2 | 0.21359107 |
| 140 | CDK9 | 0.20814538 |
| 141 | CDK6 | 0.20582436 |
| 142 | IRAK3 | 0.17709396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.24382020 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.77031719 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.60723235 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.40213007 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.05230663 |
| 6 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95001008 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.68572015 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.52469472 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44593614 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.44127601 |
| 11 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.32607535 |
| 12 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28891550 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09349894 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06321268 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99296473 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.92068734 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83726106 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83648473 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82131457 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75453364 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68980454 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68629950 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61248492 |
| 24 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.53574946 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50124269 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48560212 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45561095 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44141920 |
| 29 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.37576459 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36057579 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30809390 |
| 32 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.30065046 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.30000177 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.28335426 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.27765398 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.26515478 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.26251230 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20479265 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.18495439 |
| 40 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.16785704 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15303263 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.13160119 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12556283 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09217216 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08646238 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.05049973 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04103445 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98930024 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98097208 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96689797 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.96294823 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96052880 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95891381 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94954375 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.94635908 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92397515 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.91022085 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.90817402 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.88615183 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86706732 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.86504109 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84936626 |
| 63 | Ribosome_Homo sapiens_hsa03010 | 0.83879441 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82643602 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.82353662 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82073844 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.77089302 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.75476187 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.74358829 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71505698 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71301959 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70869868 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68491591 |
| 74 | Mismatch repair_Homo sapiens_hsa03430 | 0.65941217 |
| 75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65508951 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65021198 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64510906 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62851884 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62291522 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61631482 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60378982 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59756949 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59679927 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59055281 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55787837 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55482153 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54735196 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54605149 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52030394 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50428441 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49107973 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48703575 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48170994 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.48129970 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47442913 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45432867 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44408807 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44106391 |
| 99 | Proteasome_Homo sapiens_hsa03050 | 0.43549186 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43097221 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42135719 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41830798 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40752993 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39473882 |
| 105 | Cell cycle_Homo sapiens_hsa04110 | 0.38581006 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38515215 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38293173 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.37580047 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36224969 |
| 110 | Homologous recombination_Homo sapiens_hsa03440 | 0.35627542 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34914476 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33383248 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.32022847 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31687047 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.30805428 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30267807 |
| 117 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29746273 |
| 118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29412686 |
| 119 | Phototransduction_Homo sapiens_hsa04744 | 0.27770740 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26519595 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22313487 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21694323 |
| 123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20530484 |
| 124 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.20004582 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19210090 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.18144041 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.17175745 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16809382 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.16449514 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.13981022 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.13866361 |
| 132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.10945096 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.10483480 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.10243242 |
| 135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.09914064 |
| 136 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.07418637 |

